M. Kranendonk et al., Heterologous expression of xenobiotic mammalian-metabolizing enzymes in mutagenicity tester bacteria: An update and practical considerations, CR R TOXIC, 30(3), 2000, pp. 287-306
There is an increasing need for metabolic competent cell systems for the me
chanistic studies of biotransformation of xenobiotics in toxicology in gene
ral and in genotoxicology in particular. These cell systems combine the het
erologous expression of a particular mammalian biotransformation enzyme wit
h a specific target/end point by which a functional analysis of the express
ed gene product in the (geno)toxicity of chemicals can be performed, cDNAs
of an increasing number of mammalian biotransformation enzymes is being clo
ned. The construction of specific expression vectors permits their heterolo
gous expression in laboratory bacteria, such as Escherichia coli strains. T
his development does not only allow biochemical and enzymatic studies of (p
ure) enzyme preparations but also facilitates the engineering of metabolica
lly competent mutagenicity tester bacteria, thereby providing new tools for
genotoxicity testing and for studying of the roles of biotransformation in
chemical carcinogenesis. In this review, we describe an update as well as
an evaluation of enzymes expressed in mutagenicity tester bacteria. Four ty
pes of biotransformation enzymes are now expressed in these bacteria, namel
y, GSTs, CYPs, NATs, and STs. The expression of these enzymes in the tester
bacteria and their subsequent application in mutagenicity assays demonstra
tes that heterologous expression in this type of bacteria has a number impl
ications for the functionality of the biotransformation enzymes as well as
for the functioning of the tester bacteria in mutagenicity detection. We al
so describe here a number of practical considerations in this regard.